These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1252 related items for PubMed ID: 36091534

  • 1. Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.
    Keyu G, Jiaqi L, Liyin Z, Jianan Y, Li F, Zhiyi D, Qin Z, Xia L, Lin Y, Zhiguang Z.
    Front Public Health; 2022; 10():990281. PubMed ID: 36091534
    [Abstract] [Full Text] [Related]

  • 2. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R, Alsubaiee M, Alqarni A, Saleh Y, Aljaser S, Salam A, Eledrisi M.
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [Abstract] [Full Text] [Related]

  • 3. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH, Sapir T.
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [Abstract] [Full Text] [Related]

  • 4. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
    Yeh HC, Brown TT, Maruthur N, Ranasinghe P, Berger Z, Suh YD, Wilson LM, Haberl EB, Brick J, Bass EB, Golden SH.
    Ann Intern Med; 2012 Sep 04; 157(5):336-47. PubMed ID: 22777524
    [Abstract] [Full Text] [Related]

  • 5. Factors associated with glycemic variability in children with type 1 diabetes mellitus based on flash glucose monitoring system.
    Zhang L, Guo K, Xu Y, Bai J, Ma Y, Fu L, Liu J, Hu K, Li X, Jiang H, Yang L.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr 28; 47(4):462-468. PubMed ID: 35545341
    [Abstract] [Full Text] [Related]

  • 6. Continuous subcutaneous insulin infusion and multiple dose of insulin regimen display similar patterns of blood glucose excursions in pediatric type 1 diabetes.
    Alemzadeh R, Palma-Sisto P, Parton EA, Holzum MK.
    Diabetes Technol Ther; 2005 Aug 28; 7(4):587-96. PubMed ID: 16120030
    [Abstract] [Full Text] [Related]

  • 7. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
    Pala L, Dicembrini I, Mannucci E.
    Acta Diabetol; 2019 Sep 28; 56(9):973-980. PubMed ID: 30945047
    [Abstract] [Full Text] [Related]

  • 8. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
    Dicembrini I, Cosentino C, Monami M, Mannucci E, Pala L.
    Acta Diabetol; 2021 Apr 28; 58(4):401-410. PubMed ID: 32789691
    [Abstract] [Full Text] [Related]

  • 9. Islet Transplantation Provides Superior Glycemic Control With Less Hypoglycemia Compared With Continuous Subcutaneous Insulin Infusion or Multiple Daily Insulin Injections.
    Holmes-Walker DJ, Gunton JE, Hawthorne W, Payk M, Anderson P, Donath S, Loudovaris T, Ward GM, Kay TW, OʼConnell PJ.
    Transplantation; 2017 Jun 28; 101(6):1268-1275. PubMed ID: 27490410
    [Abstract] [Full Text] [Related]

  • 10. Glucose Variability and Time in Range in Type 2 Diabetes Treated with U-500R by Pump or Injection: CGM Findings from the VIVID Study.
    Blevins T, Lane W, Rodbard D, Sindelar D, Fan L, Ellinor K, Ilag L, Ly T, Johnson J.
    Diabetes Technol Ther; 2021 Jan 28; 23(1):51-58. PubMed ID: 32631081
    [Abstract] [Full Text] [Related]

  • 11. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
    Riemsma R, Corro Ramos I, Birnie R, Büyükkaramikli N, Armstrong N, Ryder S, Duffy S, Worthy G, Al M, Severens J, Kleijnen J.
    Health Technol Assess; 2016 Feb 28; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
    [Abstract] [Full Text] [Related]

  • 12. Optimizing type 1 diabetes after multiple daily injections and capillary blood monitoring: Pump or sensor first? A meta-analysis using pooled differences in outcome measures.
    Thomas MG, Avari P, Godsland IF, Lett AM, Reddy M, Oliver N.
    Diabetes Obes Metab; 2021 Nov 28; 23(11):2521-2528. PubMed ID: 34286892
    [Abstract] [Full Text] [Related]

  • 13. Real-time continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: results of a pilot study.
    Moreno-Fernandez J, Gomez FJ, Gazquez M, Pedroche M, García-Manzanares A, Tenias JM, Benito P, Gomez IR.
    Diabetes Technol Ther; 2013 Jul 28; 15(7):596-600. PubMed ID: 23631604
    [Abstract] [Full Text] [Related]

  • 14. Effect of the Chinese New Year Public Holiday on the Glycemic Control of T1DM With Intensive Insulin Therapy.
    Guo K, Ye J, Zhang L, Tian Q, Fan L, Ding Z, Zhou Q, Li X, Zhou Z, Yang L.
    Front Endocrinol (Lausanne); 2022 Jul 28; 13():915482. PubMed ID: 35837316
    [Abstract] [Full Text] [Related]

  • 15. Continuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.
    Medical Advisory Secretariat.
    Ont Health Technol Assess Ser; 2009 Jul 28; 9(20):1-58. PubMed ID: 23074525
    [Abstract] [Full Text] [Related]

  • 16. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J, McKay A, Ridyard C, Thornborough K, Bedson E, Peak M, Didi M, Annan F, Gregory JW, Hughes D, Gamble C.
    Health Technol Assess; 2018 Aug 28; 22(42):1-112. PubMed ID: 30109847
    [Abstract] [Full Text] [Related]

  • 17. Glucose variability as the risk factor of preeclampsia in pregnant patients with type 1 diabetes mellitus.
    Tiselko AV, Kapustin RV, Milyutina YP, Borovik NV, Abashova EI, Yarmolinskaya MI.
    J Matern Fetal Neonatal Med; 2022 Dec 28; 35(25):9639-9646. PubMed ID: 35264056
    [Abstract] [Full Text] [Related]

  • 18. Responses to continuous glucose monitoring in subjects with type 1 diabetes using continuous subcutaneous insulin infusion or multiple daily injections.
    Rodbard D, Jovanovic L, Garg SK.
    Diabetes Technol Ther; 2009 Dec 28; 11(12):757-65. PubMed ID: 20001676
    [Abstract] [Full Text] [Related]

  • 19. Glycemic Outcomes in Adults With T1D Are Impacted More by Continuous Glucose Monitoring Than by Insulin Delivery Method: 3 Years of Follow-Up From the COMISAIR Study.
    Šoupal J, Petruželková L, Grunberger G, Hásková A, Flekač M, Matoulek M, Mikeš O, Pelcl T, Škrha J, Horová E, Škrha J, Parkin CG, Svačina Š, Prázný M.
    Diabetes Care; 2020 Jan 28; 43(1):37-43. PubMed ID: 31530663
    [Abstract] [Full Text] [Related]

  • 20. Combined continuous glucose monitoring and subcutaneous insulin infusion versus self-monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trial.
    Dicembrini I, Pala L, Caliri M, Minardi S, Cosentino C, Monami M, Mannucci E.
    Diabetes Obes Metab; 2020 Aug 28; 22(8):1286-1291. PubMed ID: 32166907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.